Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study

Affiliation auteursAffiliation ok
TitreEfficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study
Type de publicationJournal Article
Year of Publication2016
AuteursPivot X., Verma S., Fallowfield L., Mueller V., Lichinitser M., A. Munoz S, Machackova Z., Osborne S., Gligorov J.
JournalANNALS OF ONCOLOGY
Volume27
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1093/annonc/mdw364.65